Our treatments are performed by experienced dermatologists using clinically approved formulations in a safe, hygienic environment, ensuring visible, consistent, and natural-looking results
As for clinical outcomes, in the T2DM group, there was a significant reduction in HbA1c (decreased by 1.01% to 1.02%, placebo-adjusted) and a clinically meaningful decrease in body weight of 3.26% to 3.51% after 12 weeks of treatment
Popular GLP-1 medications Some of the most well-known GLP-1 drugs include: Semaglutide: Sold under the names Ozempic and Wegovy by manufacturer Novo Nordisk Tirzepatide: Technically a dual GLP-1/GIP agonist, sold as Mounjaro and Zepbound, developed by Eli Lilly Liraglutide: Sold as Saxenda and Victoza (and generically), also manufactured by Novo Nordisk Forms of GLP-1 medications and FDA approval Injections : The name-brand medications listed above have all been FDA approved , but only in injectable form
GLP-1 agonists like liraglutide (Victoza), lixisenatide (Adlyxin), dulaglutide (Trulicity), and semaglutide (Ozempic, Rybelsus) are commonly prescribed and continue to demonstrate benefits beyond just controlling blood sugar, including improvements in heart and metabolic health for some drugs